Anthony Giovinazzo, XORTX’s Chairman stated, “We are delighted to welcome Michael as XORTX’s CFO. His dual science-finance background and extensive business and drug development experience will help ...

(XRTX), a late-stage clinical pharmaceutical company, Thursday announced the appointment of biotech/pharma industry ... Previously, he had a 14-year career at drug major Eli Lilly. Chairman Anthony ...

Merck has signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's experimental oral drug to treat ...

6185.HK CanSino Biologics Inc.

Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 4,32,132.22 Crore) operating in Pharmaceuticals sector. Sun Pharmaceutical ...

Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 42,840.39 Crore) operating in Pharmaceuticals sector. Glenmark Pharmaceuticals Ltd. key ...

DelveInsight's Germ Cell Tumors Market Insights report includes a comprehensive understanding of current treatment practices, ...

Biopharmaceutical company developing drugs for neurological disorders.

The dynamics of the germ cell tumors market are anticipated to change in the coming years owing to the approval of specialized therapies for GCT and anticipated greater patients getting access to ...